118 results
Page 4 of 6
8-K/A
EX-10.1
7bbvvn2lpw934fc625m
6 Mar 19
Entry into a Material Definitive Agreement
5:02pm
8-K
EX-10.1
203umflmd8qqlc4
4 Mar 19
Entry into a Material Definitive Agreement
7:05am
424B5
bdq81cx55d7 2ar
19 Feb 19
Prospectus supplement for primary offering
8:39am
8-K
EX-99.1
4co8t6fkf4tce fv
19 Feb 19
Recro Pharma Reports Financial Results for the Fourth Quarter and Year End 2018
7:05am
8-K
EX-99.2
pi5a0 fx5xvvqy9jx2
19 Feb 19
Recro Pharma Reports Financial Results for the Fourth Quarter and Year End 2018
7:05am
8-K
EX-99.1
5w8m3hgpxxyty
7 Jan 19
Other Events
7:01am
8-K
EX-10.1
3zziigozd0x2n
4 Jan 19
Entry into a Material Definitive Agreement
4:23pm
8-K
EX-99.1
d8u1iyc zpxn
10 Dec 18
Other Events
2:07pm
8-K
EX-99.2
0fwhod9 6e
7 Nov 18
Recro Pharma Reports Third Quarter 2018 Financial Results
7:06am
8-K
EX-99.1
2hc2 s1h0yg1e0
7 Nov 18
Recro Pharma Reports Third Quarter 2018 Financial Results
7:06am
8-K
EX-99.1
7hd d9wy1k24
9 Oct 18
Recro Pharma Announces PDUFA Date for IV Meloxicam
6:07am
8-K
EX-99.1
3d4h802d
1 Oct 18
Recro Announces Expansion of CDMO Service Capabilities
12:00am
8-K
EX-99.2
yj1g7lrzs386 a06
1 Oct 18
Recro Announces Expansion of CDMO Service Capabilities
12:00am
8-K
EX-99.1
hpvujxfv7mkwwj1v6wqi
7 Aug 18
Recro Pharma Reports Second Quarter 2018 Financial Results
7:05am